The GC-3 is the third edition of a long-standing and serial effort to annotate and adapt the mental disorders component of the International Classification of Diseases (ICD) to Cuban realities and needs. The Cuban Glossary since its first edition in 1975 distinctively utilizes a bottom-up and multidisciplinary developmental approach. The GC-3 as an adaptation of ICD-10 has rescued and refined the concept of neurosis and facilitated its placement throughout pertinent sections of the international classification. It has also facilitated the identification of prodromic phases of various recurrent disorders. The GC-3 endorses the view that a diagnosis should deal with several important clinical aspects in addition to illness senso stricto and that it should have a prominent therapeutic orientation. In line with this, a multiaxial schema has been included in GC-3, adding three axes to the triaxial ICD-10 adult psychiatry schema. Empirical studies are being carried out to appraise the clinical use and usefulness of the GC-3 hexaxial schema.

Keywords:
Cuban glossary of psychiatry, Culture and diagnosis, ICD-10
This content is only available via PDF.
© 2002 S. Karger AG, Basel
2002
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.